FLNA

Filana Therapeutics, Inc. - Common Stock (FLNA)

About Filana Therapeutics, Inc. - Common Stock (FLNA)

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Details

Daily high
$0.55
Daily low
$0.47
Price at open
$0.48
52 Week High
$3.45
52 Week Low
$0.39
Market cap
24.2M
Dividend yield
-
Volume
147,850
Avg. volume
455,333
P/E ratio
-.55

Filana Therapeutics, Inc. - Common Stock News

Details

Daily high
$0.55
Daily low
$0.47
Price at open
$0.48
52 Week High
$3.45
52 Week Low
$0.39
Market cap
24.2M
Dividend yield
-
Volume
147,850
Avg. volume
455,333
P/E ratio
-.55